Claims against Dr Reddy's over Revlimid in US dismissed
In a regulatory filing, the company said on December 22, 2022 and December 27, 2022, the plaintiffs voluntarily dismissed Dr Reddy's Laboratories Ltd and Dr Reddy's Laboratories, Inc. Respectively, from the case.
The complaint seeks damages for purported overpayments and equitable relief. Pic: Reuters